SciELO - Scientific Electronic Library Online

 
vol.91 número1Presencia de regurgitación moderada o grave luego del implante percutáneo de la válvula aórtica con la estrategia de “Cusp Overlap”Implicancias de la pandemia por COVID-19 y el aislamiento social sobre el perfil cardiometabólico de una cohorte de individuos en la Ciudad de Buenos Aires índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista argentina de cardiología

versão On-line ISSN 1850-3748

Resumo

LAURENZANO, Cintia S.; CHIRINO NAVARTA, Daniel A.; CERDA JORGI, María F.  e  DIAZ CASALE, Alejandra. Prognostic Value of NT-proBNP in Asymptomatic Patients with Severe Aortic Stenosis and Preserved Left Ventricular Ejection Fraction. Rev. argent. cardiol. [online]. 2023, vol.91, n.1, pp.27-33. ISSN 1850-3748.  http://dx.doi.org/10.7775/rac.es.v91.i1.20596.

Background

: The aortic valve replacement (AVR) indication in asymptomatic patients with severe aortic stenosis (AS) and preserved function is being increasingly discussed.

Objective

: The aim of this study was to evaluate whether the elevation of the N-terminal fraction of the pro-B-type natriuretic peptide (NT-proBNP) predicts the occurrence of symptoms and the AVR indication in patients with severe AS and preserved left ventricular ejection fraction (LVEF), initially asymptomatic.

Methods

: Asymptomatic patients with severe AS, preserved EF (≥55%) and no initial AVR indication were prospectively included. All patients underwent laboratory tests measuring NT-proBNP at baseline and an echocardiogram with tissue Doppler recording the lateral wall S wave (lat. S) and the E/e´ ratio. The endpoint was the aortic valve replacement indication at follow-up.

Results

: We included 133 patients aged 69 ± 8 years, 49% of which were women. After a follow-up of 570 (interquartile range 380-680) days, 23.3% (n=31) of them required aortic valve replacement. In the multivariate analysis, NT-proBNP value and the E/e´ ratio were 2 independent predictors of surgery (HR 1.02, 95% CI 1.001-1.03) p<0.001 and HR 1.42, 95% CI 1.21- 2.45, p< 0.001, respectively). NT-proBNP presented an area under the curve (AUC) greater than the E/e’ ratio (0.88 versus 0.64, p=0.02). The best NT-proBNP cut-off point was determined >350 pg/mL (adjusted HR 1.55, 95% CI 1.38-2.01, p<0.001)

Conclusion

: NT-proBNP value and the E/e´ ratio were independent predictors of the AVR requirement. NT-proBNP had a very good discrimination capacity, greater than the E/e´ ratio.

Palavras-chave : Aortic Valve Stenosis; Biomarkers; Natriuretic Peptide; Brain.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )